Two large studies of the top-selling cancer drug Avastin released Thursday show that the drug can slow the growth of ovarian cancer when added to chemotherapy. But in a disappointment for patients, neither study found that the expensive drug extends life expectancy. “The amount of improvement seems to be relatively modest,” said Amit Oza, an oncologist at the Princess Margaret Hospital in ...